Interferon γ Gene Expression in Sensory Neurons: Evidence for Autocrine Gene Regulation

DRG were prepared from Wistar rat fetuses (E15) obtained from the breeding facility (Max-Planck-Institute for Psychiatry) as previously described (11). In brief, DRG were removed from the fetuses and were dissociated by 0.1% trypsin (Worthington Biochemical Corporation, Freehold, NJ). Cells were dissociated by trituration and were cultured on poly-l-ornithine (0.1 mg/ml, Sigma Chemical Co., Taufkirchen, Germany) plus laminin-coated (10 μg/ml, gift from Dr. Ries, Max-Planck-Institute for Biochemistry, Martinsried, Germany) dishes in DMEM medium (GIBCO BRL, Eggenstein, Germany) supplemented with 10% fetal calf serum (Pansystems GmbH, Nürnberg, Germany) and 10 ng/ml nerve growth factor (NGF-7S mouse, Sigma Chemical Co.). On the first day cells were treated for 24 h with 10 μM 5-fluoro-2-deoxyuridine (Sigma Chemical Co.) and 10 μM uridine (Sigma Chemical Co.) to inhibit growth of nonneuronal cells. Antibodies neutralizing IFN-γ (30 μg/ml, DB1; Laboserv, Gießen, Germany) were added to the cell culture as described in the text. Hippocampal cell cultures (12) and T cell cultures (13) were performed as previously described.

Whole cell recording and reverse transcription of cytoplasmic RNA from single neurons was performed as previously described (14). Cytoplasmic RNA of individual CD4⁺ myelin basic protein-specific T lymphoblasts (13) and of satellite cells from the DRG culture was collected with the patch-clamp pipette and was reverse transcribed using the same protocol as previously described (14). Oligonucleotides for PCR amplification were selected with program PRIMER (Whitehead Institute, Cambridge, MA) and were produced by the Max-Planck-Institute for Biochemistry (Martinsried, Germany). Forward primer and reverse primer were always chosen from different exons to detect possible amplification of genomic DNA contamination. The primer sequences were as follows: for rat IFN-γ (These sequence data are available from EMBL/GenBank/DDBJ under accession numbers X02326 and X02327), 5′-AGGATGCATTCATGAGCATCGCC-3′ (385–407) and 5′-CACCGACTCCTTTTCCGCTTCCT-3′ (223–201); and for rat CD4 (W3/25; accession number M15768), 5′-GTGCCGAGGCTTCTCTTTCAGG-3′ (56–77) and 5′-CCCAGAATTGTCTTTTGGTCAGAGG-3′ (247–273). The primer sequences for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glial fibrillary acidic protein (GFAP), and IFN-γ–receptor have been previously described (14). PCR-amplification was done in a final volume of 50 μl containing 1 μl of transcribed cDNA probe, the four deoxyribonucleotide triphosphates (final 0.2 mM, Pharmacia), 2.5 U AmpliTaq (Perkin-Elmer/Applied Biosystems GmbH, Weiterstadt, Germany) and 1× PCR-buffer (Perkin-Elmer/Applied Biosystems GmbH) covered with two drops of mineral oil (Sigma Chemical Co.). Before PCR amplification on a programmable thermocycler (MultiCycler PTC 200, MJ Research Inc.), denaturated primers (final 100 pmol primers) were added to each tube at 80°C. The cDNA was denaturated at 95°C for 3 min. PCR was performed on cDNA from single cells with 48–50 cycles (93°C for 60 s; ramp with 0.1°C/s from 93°C to 60°C; 60°C for 60 s; 72°C for 60 s) and followed by one final cycle at 72°C for 5 min. 10 μl of the amplified fragments was run along with the molecular weight marker (ΦX 174, HaeIII digested; Pharmacia Biotech, Freiburg, Germany) on a 1.7% agarose gel electrophoresis stained with ethidium bromide. For Southern blot analysis the DNA fragments of the gel were transferred onto a nylon membrane (Hybond N+, Amersham Buchler, Braunschweig, Germany). The resulting blot was hybridized with a rat IFN-γ–specific probe (rat IFN-γ; these sequence data are available from EMBL/ GenBank/DDBJ under accession number X02327: 130–153) using the Digoseigenin Southern blot Hybridization System (Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's instructions. For sequencing, the PCR fragments were gel-purified (QIAGEN, Hilden, Germany) and were sequenced by MediGene (Martinsried, Germany) with an automated sequence analyzer.

Cultured rat DRG neurons or frozen sections of rat lumbar DRG were fixed with 4% paraformaldehyde in PBS. For labeling of MHC class I molecules on the cell membrane, mouse monoclonal antibodies directed against MHC class I (Ox 18, 10 μg/ml; Serotec Ltd., Oxford, England) were added to the cell culture for 60 min before fixation. Nonspecific binding sites were blocked with PBS containing 2% goat serum and 2% bovine albumin. For intracellular labeling, cultured cells were treated with PBS containing 0.1% Triton X-100 for 30 min. In the first step, cells or tissue sections were labeled with mouse monoclonal antibodies recognizing rat IFN-γ (DB1; 10 μg/ml), mouse monoclonal antibodies directed against STAT1 (5 μg/ml; PharMingen, Hamburg, Germany), rabbit polyclonal antibodies recognizing an epitope of IFN-γ–receptor α chain corresponding to amino acids 461–477 (2 μg/ml, K-17; Santa Cruz Biotechnology, Heidelberg, Germany), or rabbit polyclonal antibodies recognizing an epitope of IFN-γ–receptor β chain corresponding to amino acids 312–331 (2 μg/ml, M-20; Santa Cruz Biotechnology) followed by secondary fluorochrome Cy3–conjugated goat antibodies directed against mouse or rabbit immunoglobulin (10 μg/ml; Dianova, Hamburg, Germany). In a second step, cells were double-labeled with mouse monoclonal antibodies recognizing neurofilament (2 μg/ml, NN18; Boehringer Mannheim) followed by fluorochrome (dichlorotriazinyl) aminofluorescein–conjugated antibodies to mouse immunoglobulin (5 μg/ml; Dianova, Hamburg, Germany). Conventional photographs were taken with an immunofluorescence microscope (Carl Zeiss, Oberkochen, Germany). Confocal images were acquired with a confocal laser scanning microscope (Leica, Bensheim, Germany) equipped with ×63 oil objectives. Baseline labeling for the IFN-γ, STAT1, and MHC class I staining procedures was revealed with irrelevant mouse monoclonal antibodies (10 μg/ml; Dianova) and secondary fluorochrome Cy3–conjugated goat antibodies to mouse immunoglobulin (10 μg/ml; Dianova). Baseline labeling for the IFN-γ–receptor α and β chains was revealed by adding the corresponding (blocking) peptides (2 μg/ml; Santa Cruz Biotechnology) to the polyclonal rabbit antibodies, followed by secondary fluorochrome Cy3–conjugated goat antibodies to rabbit immunoglobulin (10 μg/ml; Dianova).

Data were determined by three independent experiments and are indicated as mean ± SEM. Analyses of STAT1 as well as of MHC class I by confocal laser scanning microscopy revealed significant (P <0.01) difference between the untreated and IFN-γ neutralizing antibody–treated group in the unpaired two-tail Student's t test.

Histological sections were performed from rat lumbar DRG tissue. IFN-γ immunolabeling was detectable in a subpopulation of DRG cells during peri- and postnatal development (Fig. 1). Histological sections showed strong IFN-γ expression at embryonic day 18 and during the first 2 wk after birth. The in situ IFN-γ labeling was very prominent in the neuronal perikarya, but was also demonstrable in the neuronal processes (Fig. 1).

DRG cells from embryonic rats (E15) were cultured in the presence of nerve growth factor. Most of the DRG neurons that differentiated in vitro bound monoclonal antibodies recognizing IFN-γ. Specific immunofluorescence was detected after 7 d in culture in 83 ± 8% of DRG neurons identified by neurofilament labeling, but in none of the nonneuronal cells (Fig. 2). Confocal laser scanning microscopy localized the IFN-γ proteins in the cytoplasm, sparing the nucleus and the cell membrane (Fig. 2), whereas processes and dendrites showed no or only very weak reactivity.

After 7 d in culture, neurons could be distinguished morphologically from nonneuronal cells. Their neuronal identity was ascertained by whole cell patch-clamp electrophysiology (15). As expected, the DRG-derived neurons showed sodium currents activated at different membrane potentials, and responded to current pulses of increasing amplitude with sodium action potentials (Fig. 3).

We then used single-cell RT-PCR analysis to identify the intraneuronal IFN-γ–like material. After electrophysiological characterization, we sampled cytoplasmic specimens from individual neurons through the patch-clamp micropipette, and assessed current gene transcription by RT-PCR. Oligonucleotides specific for IFN-γ were used to amplify gene transcripts for the cytokine. In addition, as in our previous studies, coamplification of mRNA for the house-keeping enzyme GAPDH and for cell lineage markers served as internal quality standards (12, 14). The validity of our method was corroborated by parallel analyses of activated CD4⁺ T lymphocytes with a Th1-like phenotype (13) and DRG-derived glia cells (Fig. 4). Each single T lymphoblast analyzed contained mRNA for the lineage marker gene CD4 along with IFN-γ. In contrast, satellite cells from DRG cultures, which expressed glia specific GFAP gene transcripts, and were negative for IFN-γ and CD4 gene transcripts (Fig. 4). In a subsequent cytokine study of 19 individual DRG neurons, mRNA for IFN-γ was identified in 13 cells cultured for 7 d (Fig. 5). Southern blot analysis and sequencing confirmed the identity of the amplified fragments with classic IFN-γ. IFN-γ gene expression in cultured DRG neurons developed steadily over time. Among neurons cultured for 2 h, only a minority (1/11) of the (electrophysiologically immature) cells expressed IFN-γ gene transcripts (Fig. 5). However, the percentage of IFN-γ–expressing neurons continuously increased through the first 24 h in culture. After 6 h, 3/13 neurons, and after 24 h, 7/11 DRG neurons, expressed IFN-γ gene transcripts. In contrast, differentiated neurons derived from hippocampus tissue transcribed IFN-γ at no time.

IFN-γ acts on its target cells by binding to and activating membrane-bound IFN-γ receptors, heterodimeric proteins composed by a cytokine-binding α chain and signal-transducing β chain (16). Gene transcripts for the IFN-γ receptor α chains were detected in all DRG neurons analyzed (Fig. 6) Membrane expression of the receptor complex was confirmed by immunofluorescence and confocal laser scanning microscopy. IFN-γ–receptor α chain–specific antibodies labeled 98 ± 4% of neurofilament-positive DRG neurons, predominantly on the cell membrane (Fig. 7). The signal-transducing β chain was detected on 97 ± 5% sensory neurons (Fig. 7). Simultaneous expression of a cytokine along with its specific receptor in the same cell provides a necessary, although insufficient, structural basis for autocrine regulation. This is the proven case in IFN-γ production by activated T lymphocytes (17), and could also hold true for our cultured DRG neurons. Since the binding of IFN-γ to its receptors results in phosphorylation and translocation of the transcriptional factor STAT1 from the cytoplasm to the nucleus (16), both features of STAT1 activation should be demonstrable in the cells of our DRG cultures, and should be reversed by the addition of neutralizing antibodies against IFN-γ.

Western blot analysis of total cell lysate of DRG cultures demonstrated phosphorylated STAT1 (data not shown), but this method does not identify the cell type in the mixed DRG culture that has the active form of STAT1. However, confocal laser scanning microscopy clearly located STAT1 in the nuclei of almost all cultured neurofilament-positive DRG neurons (96 ± 4%, Figs. 8 and 9), and also in the glia cells. In contrast, in differentiated hippocampal neuronal cultures, where no IFN-γ synthesis is demonstrable, all STAT1 immunoreactivity was confined to the cytoplasm (Fig. 8). IFN-γ–neutralizing antibodies to DRG cultures profoundly interfered with nuclear translocation of STAT1. After neutralization of IFN-γ, most neurons displayed STAT1 within their cytoplasm, with nuclear location seen only in a minority of all cells (26 ± 11%, Figs. 8 and 9).

The possible auto/paracrine action of neuronal IFN-γ was supported by an investigation of MHC class I expression on cultured DRG neurons. As previously reported, IFN-γ readily induces MHC class I genes in electrically silent neurons, but much less so in firing neurons (12, 14). Adult sensory DRG neurons are silent in culture, and are susceptible to MHC class I induction by IFN-γ (18). Thus, in the case of autocrine activity of neuronal IFN-γ, cultured IFN-γ–secreting neurons should constitutively express MHC class I on their membranes. That this is the case was documented by confocal microscopy with MHC class I expression on 67 ± 11% of all sensory neurons (cultured for 5 d and identified by a neurofilament marker, Figs. 8 and 9). Treatment of the DRG culture with neutralizing anti–IFN-γ monoclonal antibodies reduced the proportion of MHC class I–positive neurons to 14 ± 3% (Fig. 9).

Over the past few years it has become clear that numerous humoral mediators that originally had been thought to act exclusively either in the immune system or in the nervous system in fact interconnect both organ systems. For example, neurotrophic factors like nerve growth factor are not restricted to neural cells, but are produced by and act on immune cells as well (19). Conversely, a number of cytokines with classical immune functions are also effective in nervous tissues. Proinflammatory cytokines like TNF-α or IL-1 influence neuronal function and behavior (20). A proportion of these mediators may be imported through the blood brain barrier or discharged in the central nervous system by immigrant inflammatory cells. But it has also become clear that many of these cytokines are produced and released within the nervous system by autochthonous cells (21, 22). In this study, we have shown that classical IFN-γ is produced and used by neurons in the peripheral nervous system.

Autocrine gene regulation is a common feature of the cytokine network. For example, IFN-γ produced by subsets of activated T cells activates STAT1 factor and thereby upregulates its own gene expression (17, 23). Likewise, in the brain, neurotrophils such as brain-derived neurotrophic factor prevent death of adult sensory neurons acting in autocrine loops (24). Our results now suggest that STAT1 activation in neurons is at least partially regulated by IFN-γ produced by the same cells. Although neutralization of IFN-γ by monoclonal antibodies suppressed MHC class I membrane expression on neurons almost completely, this procedure inhibited phosphorylation and translocation of STAT1 only partially. This can be explained by the activity of neural mediators ligating the gp130 receptor of the IL-6/CNTF family of cytokines, which uses besides STAT3 also the STAT1 activation pathway (25).

Most reports on IFN-γ activity within the nervous system are related to inflammatory responses, as represented by experimental autoimmune encephalomyelitis, multiple sclerosis, or microbial brain infections. In these situations, the cytokine is mainly produced and released by infiltrating immune cells (26). This is in contrast to neuronal IFN-γ, whose particular temporal and spatial expression patterns suggest a developmental function, possibly related to the differentiation of peripheral nerves.

Autocrine IFN-γ secretion by DRG neurons may contribute signals controlling neuronal differentiation (4), like activation of neuron-specific genes encoding the peripheral nerve type 1 sodium channel (5). Other possible targets of IFN-γ–dependent regulation are the genes controlling neuron transmitter production (6). Alternatively, DRG neuronal IFN-γ could regulate glia cells surrounding the neurons in situ. In vitro, IFN-γ interferes with myelination of central nervous system (27) and peripheral nerve myelination (28). In agreement with this, transgenic mice constitutively producing IFN-γ in their central nervous system display a “tremoring” phenotype coinciding with a “dramatic overall decrease in central nervous system myelin” (29).

Demonstration of local production of IFN-γ by small and medium sized DRG neurons (which are enriched in our nerve growth factor–dependent culture model) and its auto/paracrine action on local cells predicts a new and unexpected function of this unusually pleiotropic proinflammatory cytokine.

We thank Ms. L. Penner for expert technical assistance; Drs. R. Böhm-Matthaei, E. Hoppe, R. Kiefer, and H.-P. Hartung for technical advice; Dr. A. Ries for supplying us with laminin; Dr. G. Kääb for culturing T lymphoblasts; and Dr. I. Medana for helpful discussion.